Pfizer Inc banner

Pfizer Inc
SGO:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
SGO:PFE
Watchlist
Price: 49.19 USD -0.36% Market Closed
Market Cap: $165.2B

Relative Value

The Relative Value of one PFE stock under the Base Case scenario is hidden USD. Compared to the current market price of 49.19 USD, Pfizer Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

PFE Competitors Multiples
Pfizer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pfizer Inc
SGO:PFE
153.9B USD 2.5 19.8 7.4 9.9
US
Eli Lilly and Co
NYSE:LLY
992.9B USD 15.2 48.1 32.4 34.5
US
Johnson & Johnson
NYSE:JNJ
575.5B USD 6.1 21.5 14.9 18.3
CH
Roche Holding AG
SIX:ROG
283.1B CHF 4.6 30 12.7 14.8
CH
Novartis AG
SIX:NOVN
231.6B CHF 5.3 21.3 13.2 16.9
UK
AstraZeneca PLC
LSE:AZN
215.3B GBP 5.2 31.9 15.2 22.3
US
Merck & Co Inc
NYSE:MRK
291.1B USD 4.5 16 10 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.6 10 11.7
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Bristol-Myers Squibb Co
NYSE:BMY
123.2B USD 2.6 17.5 6.8 8.8
UK
GlaxoSmithKline PLC
LSE:GSK
88.1B GBP 2.7 15.5 7.8 11.1
P/E Multiple
Earnings Growth PEG
US
Pfizer Inc
SGO:PFE
Average P/E: 23.5
19.8
26%
0.8
US
Eli Lilly and Co
NYSE:LLY
48.1
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.5
7%
3.1
CH
Roche Holding AG
SIX:ROG
30
29%
1
CH
Novartis AG
SIX:NOVN
21.3
15%
1.4
UK
AstraZeneca PLC
LSE:AZN
31.9
38%
0.8
US
Merck & Co Inc
NYSE:MRK
16
14%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
13.6
7%
1.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
UK
GlaxoSmithKline PLC
LSE:GSK
15.5
18%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Pfizer Inc
SGO:PFE
Average EV/EBITDA: 42.1
7.4
-4%
N/A
US
Eli Lilly and Co
NYSE:LLY
32.4
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
14.9
2%
7.5
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
CH
Novartis AG
SIX:NOVN
13.2
9%
1.5
UK
AstraZeneca PLC
LSE:AZN
15.2
10%
1.5
US
Merck & Co Inc
NYSE:MRK
10
7%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10
7%
1.4
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
SGO:PFE
Average EV/EBIT: 90.5
9.9
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
34.5
17%
2
US
Johnson & Johnson
NYSE:JNJ
18.3
6%
3.1
CH
Roche Holding AG
SIX:ROG
14.8
6%
2.5
CH
Novartis AG
SIX:NOVN
16.9
12%
1.4
UK
AstraZeneca PLC
LSE:AZN
22.3
23%
1
US
Merck & Co Inc
NYSE:MRK
11.7
6%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
8%
1.5
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-6%
N/A
UK
GlaxoSmithKline PLC
LSE:GSK
11.1
12%
0.9